Andreas Kerschbaumer

Rheumatology

900 Blake Wilbur Dr Fl 2
Palo Alto, CA 94304

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Rheumatoid Arthritis in Adults: A Review.

Rheumatoid Arthritis in Adults: A Review.

Journal: JAMA

Published: September 10, 2026

Clinical and imaging features of haemochromatosis arthropathy: a systematic literature review and meta-analysis to inform the development of EULAR classification criteria.

Clinical and imaging features of haemochromatosis arthropathy: a systematic literature review and meta-analysis to inform the development of EULAR classification criteria.

Journal: EULAR rheumatology open

Published: June 29, 2026

Response to correspondence by Dr Aamar on 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update'.

Response to correspondence by Dr Aamar on 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update'.

Journal: Annals of the rheumatic diseases

Published: June 18, 2026

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

Journal: Nature medicine

Published: March 13, 2026

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Journal: Annals of the rheumatic diseases

Published: February 16, 2026

Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials.

Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials.

Journal: Rheumatology (Oxford, England)

Published: January 23, 2026

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: December 08, 2025

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: December 02, 2025

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Journal: Annals of the rheumatic diseases

Published: November 25, 2025

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.

Journal: Annals of the rheumatic diseases

Published: November 21, 2025

Response to 'Correspondence on 'Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update' by Nash et al.' by Telliez et al.

Response to 'Correspondence on 'Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update' by Nash et al.' by Telliez et al.

Journal: Annals of the rheumatic diseases

Published: November 10, 2025

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trial.

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trial.

Journal: Trials

Published: September 03, 2025

Showing 1-12 of 69

Last Updated: 11/08/2026